Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study - Conteduca, Vincenza (Centre for Evolution and Cancer. The Institute of Cancer Research, London) ; Wetterskog, Daniel (Centre for Evolution and Cancer. The Institute of Cancer Research, London) ; Sharabiani, M. T. A. (Royal Marsden NHS Foundation Trust. Research Data Management and Statistics Unit) ; Grande, Enrique (Hospital Universitario Ramón y Cajal (Madrid)) ; Fernandez Perez, M. P. (Hospital General Universitario Morales Meseguer (Múrcia)) ; Jayaram, Anuradha (Centre for Evolution and Cancer. The Institute of Cancer Research, London) ; Salvi, S. (Istituto Scientifico Romagnolo per lo Studio e Cura dei Tumori (IRST) IRCCS) ; Castellano, Daniel (Hospital Universitario 12 de Octubre (Madrid)) ; Romanel, A. (Università di Trento. Centro di Biologia Integrata) ; Lolli, C. (Istituto Scientifico Romagnolo per lo Studio e Cura dei Tumori (IRST) IRCCS) ; Casadio, Valentina (Istituto Scientifico Romagnolo per lo Studio e Cura dei Tumori (IRST) IRCCS) ; Gurioli, Giorgia (Istituto Scientifico Romagnolo per lo Studio e Cura dei Tumori (IRST) IRCCS) ; Amadori, D. (Istituto Scientifico Romagnolo per lo Studio e Cura dei Tumori (IRST) IRCCS) ; Font Guiteras, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Vazquez Estevez, S. (Hospital Universitario Lucus Augusti (Lugo)) ; González-del-Alba, Aránzazu (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Mellado, B. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Fernandez Calvo, O. (Complejo Hospitalario Universitario de Ourense) ; Méndez Vidal, M. J. (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ; Climent, Miguel Ángel (Fundació Institut Valencià d'Oncologia) ; Durán, Ignacio (Instituto de Biomedicina de Sevilla) ; Gallardo, Eduard (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Rodríguez Sánchez, Ángel (Hospital Universitario de León) ; Santander, C. (Hospital Universitario Miguel Servet (Saragossa)) ; Sáez, M. I. (Hospital Regional Universitario de Málaga) ; Puente, J. (Hospital Clínico San Carlos (Madrid)) ; Gasi Tandefelt, D. (Centre for Evolution and Cancer. The Institute of Cancer Research, London) ; Wingate, Anna (Centre for Evolution and Cancer. The Institute of Cancer Research, London) ; Dearnaley, David (Royal Marsden NHS Foundation Trust. Academic Urology Unit) ; Demichelis, F. (Università di Trento. Centro di Biologia Integrata) ; De Giorgi, Ugo (Istituto Scientifico Romagnolo per lo Studio e Cura dei Tumori (IRST) IRCCS) ; Gonzalez-Billalabeitia, Enrique (Hospital General Universitario Morales Meseguer (Múrcia)) ; Attard, Gerhardt (Centre for Evolution and Cancer. The Institute of Cancer Research, London) ; Spanish Oncology Genitourinary Group ; Universitat Autònoma de Barcelona